Sign in →

Test Code LABMDONCOSCRNCYT OncoScreen FFPE/Cytology

Specimen and Container/Tube

Specimen Type: Tumor Tissue

Preferred Specimen: FFPE Slides or Cytology Smear

Other Acceptable Specimens: not applicable

Appropriate specimens should contain >20% tumor cells and enough total cells to produce adequate DNA yield (typically >50,000 total cells (FFPE) or >2000 total cells (cytology smear)). Specimens with less than 20% tumor cells may be tested at the discretion of the attending molecular pathologist.

Specimen Stability

n/a

Collection Instructions

Collect specimen per standard laboratory collection procedures.

Specimen Handling and Transport Instructions

UCM Onsite Instructions: Collect specimen per standard collection procedured and send to the laboratory immediately.

Clinical Indications

Targeted and rapid assay covering hotspot regions in 50 cancer associated genes for genomic profiling of solid tumor and hematological malignancy specimens to determine appropriate therapies. It also can be useful for diagnosis, prognosis, clinical trials selection and for translational research.

CPT Codes

81445
88381

Methodology

Next generation sequencing

Additional Information

Detects hotspot regions in 50 genes that are commonly mutated in cancer: ABL1, AKT1, ALK, APC, ATM, BRAF, CDH1, CDKN2A, CSF1R, CTNNB1, EGFR, ERBB2, ERBB4, EZH2, FBXW7, FGFR1, FGFR2, FGFR3, FLT3, GNA11, GNAQ, GNAS, HNF1A, HRAS, IDH1, IDH2, JAK2, JAK3, KDR, KIT, KRAS, MET, MLH1, MPL, NOTCH1, NPM1, NRAS, PDGFRA, PIK3CA, PTEN, PTPN11, RB1, RET, SMAD4, SMARCB1, SMO, SRC, STK11, TP53, VHL. Will not detect mutations below the analytical sensitivity of the assay (5% variant allelic frequency).

Ordering Notes

For questions about Molecular Pathology orders, email MolecularDxLab@uchicagomedicine.org

Volume

Preferred Volume: >10 slides (FFPE), 1 slide (Cytology smear)

Minimum Volume: 10 slides (FFPE), 1 slide (Cytology Smear)

Unstained slides containing FFPE tissue are acceptable. At least 10 microtome sections of 5 micron thickness should be submitted for testing. One adequate cytology smear should be submitted for testing.

Turnaround Time

Turnaround times are relative to the time the specimen is received in the testing laboratory section.

STAT Turnaround Time: n/a
Routine Turnaround Time: ≤10 days

Testing Schedule: M-F 7:00am-5:00pm

Infectious Specimen

N/A

Search Keywords

Hotspot panel, cancer, mutation, NGS, NextGen, Sequencing, Gene